A new algorithm has been developed which personalises which cancer mutations are best targets for immunotherapy.
List view / Grid view
Abramson Cancer Center at the University of Pennsylvania
Filter the results
Researchers have found that inhibiting a kinase in mice leads to the death of prostate cancer cells, providing a potential therapeutic target.